Source:http://linkedlifedata.com/resource/pubmed/id/17823803
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
2007-9-17
|
| pubmed:abstractText |
The use of botulinum toxin A for the treatment of wrinkles is increasing. Botulinum toxin A inhibits exocytosis of acetylcholine from 3 to 12 months, depending on the target tissue. Low-dose botulinum toxin A is used to smooth hyperkinetic facial lines. This is especially successful in the upper facial parts, since the target muscles (procerus, corrugator supracilii, frontalis, orbicularis oculi) all directly overlie the osseous structures of the face. This is not the case for the lower facial parts, and more side effects are encountered when treating, for example, wrinkles around the mouth. Contraindications to the use of botulinum toxin A are diseases affecting neuromuscular signal transduction, allergic reactions to components of the solution, therapy with aminoglycosides or acetylsalicylic acid prior to treatment, infections in the planned treatment area, and pregnancy and lactation. Alternative and complementary treatments include erbium-YAG or CO2 laser, as well as augmentation and surgical plastic procedures.
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0941-293X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
104
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
777-82
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:17823803-Adult,
pubmed-meshheading:17823803-Animals,
pubmed-meshheading:17823803-Botulinum Toxins, Type A,
pubmed-meshheading:17823803-Combined Modality Therapy,
pubmed-meshheading:17823803-Esthetics,
pubmed-meshheading:17823803-Face,
pubmed-meshheading:17823803-Facial Muscles,
pubmed-meshheading:17823803-Female,
pubmed-meshheading:17823803-Haplorhini,
pubmed-meshheading:17823803-Humans,
pubmed-meshheading:17823803-Injections, Intramuscular,
pubmed-meshheading:17823803-Lactation,
pubmed-meshheading:17823803-Laser Therapy,
pubmed-meshheading:17823803-Lethal Dose 50,
pubmed-meshheading:17823803-Middle Aged,
pubmed-meshheading:17823803-Neuromuscular Agents,
pubmed-meshheading:17823803-Posture,
pubmed-meshheading:17823803-Pregnancy,
pubmed-meshheading:17823803-Rhytidoplasty,
pubmed-meshheading:17823803-Skin Aging,
pubmed-meshheading:17823803-Surgery, Plastic,
pubmed-meshheading:17823803-Time Factors,
pubmed-meshheading:17823803-Treatment Outcome
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
[Treatment of wrinkles with botulinum toxin].
|
| pubmed:affiliation |
Augenklinik der TU München, Ismaninger Strasse 22, 81675 München. ines.lanzl@lrz.tu-muenchen.de
|
| pubmed:publicationType |
Journal Article,
English Abstract
|